The novel treatment of this peptide represents a major development in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – GLP-1 and GIP – resulting in greater sugar https://tirzepatidepeptide059110.daneblogger.com/40649028/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment